Research Summary
Respiratory Distress Syndrome (RDS), also known as hyaline membrane disease, is a serious respiratory condition primarily affecting premature infants. It is characterized by insufficient production of surfactant, a substance that helps keep the air sacs in the lungs open and facilitates breathing. Without adequate surfactant, the infant's lungs become stiff, making it difficult for them to expand and contract properly. This results in respiratory difficulties, including rapid breathing, labored breathing, and low oxygen levels in the blood. RDS is most common in infants born before 28 weeks of gestation, as surfactant production usually begins in the third trimester of pregnancy. Treatment often involves providing respiratory support through mechanical ventilation and administering exogenous surfactant. While advancements in neonatal care have improved outcomes, RDS remains a significant challenge in the care of premature infants.
According to DIResearch's in-depth investigation and research, the global Respiratory Distress Syndrome market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Respiratory Distress Syndrome include Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Respiratory Distress Syndrome. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Respiratory Distress Syndrome market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Respiratory Distress Syndrome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Respiratory Distress Syndrome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Respiratory Distress Syndrome Include:
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Respiratory Distress Syndrome Product Segment Include:
Poractant Alfa
Beractant
Calfactant
Others
Respiratory Distress Syndrome Product Application Include:
Very Preterm Infants
Moderate to Late Preterm Infants
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Respiratory Distress Syndrome Industry PESTEL Analysis
Chapter 3: Global Respiratory Distress Syndrome Industry Porter's Five Forces Analysis
Chapter 4: Global Respiratory Distress Syndrome Major Regional Market Size and Forecast Analysis
Chapter 5: Global Respiratory Distress Syndrome Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Respiratory Distress Syndrome Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Respiratory Distress Syndrome Market Overview 1.1 Product Definition and Statistical Scope 1.2 Respiratory Distress Syndrome Product by Type 1.2.1 Global Respiratory Distress Syndrome Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Poractant Alfa 1.2.3 Beractant 1.2.4 Calfactant 1.2.5 Others 1.3 Respiratory Distress Syndrome Product by Application 1.3.1 Global Respiratory Distress Syndrome Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Very Preterm Infants 1.3.3 Moderate to Late Preterm Infants 1.3.4 Others 1.4 Global Respiratory Distress Syndrome Market Revenue Analysis (2019-2030) 1.5 Respiratory Distress Syndrome Market Development Status and Trends 1.5.1 Respiratory Distress Syndrome Industry Development Status Analysis 1.5.2 Respiratory Distress Syndrome Industry Development Trends Analysis 2 Respiratory Distress Syndrome Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Respiratory Distress Syndrome Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Respiratory Distress Syndrome Market Analysis by Regions 4.1 Respiratory Distress Syndrome Overall Market: 2023 VS 2024 VS 2030 4.2 Global Respiratory Distress Syndrome Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Respiratory Distress Syndrome Revenue and Market Share by Region (2019-2024) 4.2.2 Global Respiratory Distress Syndrome Revenue Forecast by Region (2025-2030) 5 Global Respiratory Distress Syndrome Market Size by Type and Application 5.1 Global Respiratory Distress Syndrome Market Size by Type 5.2 Global Respiratory Distress Syndrome Market Size by Application 6 North America 6.1 North America Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Respiratory Distress Syndrome Market Size by Type 6.4 North America Respiratory Distress Syndrome Market Size by Application 6.5 North America Respiratory Distress Syndrome Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Respiratory Distress Syndrome Market Size by Type 7.4 Europe Respiratory Distress Syndrome Market Size by Application 7.5 Europe Respiratory Distress Syndrome Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Respiratory Distress Syndrome Market Size by Type 8.4 China Respiratory Distress Syndrome Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Respiratory Distress Syndrome Market Size by Type 9.4 APAC (excl. China) Respiratory Distress Syndrome Market Size by Application 9.5 APAC (excl. China) Respiratory Distress Syndrome Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Respiratory Distress Syndrome Market Size by Type 10.4 Latin America Respiratory Distress Syndrome Market Size by Application 10.5 Latin America Respiratory Distress Syndrome Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Type 11.4 Middle East & Africa Respiratory Distress Syndrome Market Size by Application 11.5 Middle East & Africa Respiratory Distress Syndrome Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Respiratory Distress Syndrome Market Revenue by Key Manufacturers (2020-2024) 12.2 Respiratory Distress Syndrome Competitive Landscape Analysis and Market Dynamic 12.2.1 Respiratory Distress Syndrome Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Chiesi Farmaceutici 13.1.1 Chiesi Farmaceutici Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Chiesi Farmaceutici Respiratory Distress Syndrome Product Portfolio 13.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 CR-Double Crane 13.2.1 CR-Double Crane Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 CR-Double Crane Respiratory Distress Syndrome Product Portfolio 13.2.3 CR-Double Crane Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 ONY Biotech 13.3.1 ONY Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 ONY Biotech Respiratory Distress Syndrome Product Portfolio 13.3.3 ONY Biotech Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 AbbVie 13.4.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 AbbVie Respiratory Distress Syndrome Product Portfolio 13.4.3 AbbVie Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Yuhan Corporation 13.5.1 Yuhan Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Yuhan Corporation Respiratory Distress Syndrome Product Portfolio 13.5.3 Yuhan Corporation Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 JW Pharmaceuticals 13.6.1 JW Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 JW Pharmaceuticals Respiratory Distress Syndrome Product Portfolio 13.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Noargen 13.7.1 Noargen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Noargen Respiratory Distress Syndrome Product Portfolio 13.7.3 Noargen Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Respiratory Distress Syndrome Industry Chain Analysis 14.2 Respiratory Distress Syndrome Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Respiratory Distress Syndrome Typical Downstream Customers 14.4 Respiratory Distress Syndrome Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support